Aventis Pharma S.A. v. Amphastar Pharms. Inc.

Federal Circuit: May 14, 2008

Appeal from the Central District of California

Before: Moore, Prost, Rader

Full Text: PDF

Tagged: ip

Authorities Cited: United States Patent and Trademark Office U.S. Patent No. 4,460,363 U.S. Patent No. 5,389,618 United States Code 28 U.S.C. § 1295(a)(1) 35 U.S.C. § 102 35 U.S.C. § 102(b) 35 U.S.C. § 103 Code of Federal Regulations 37 C.F.R. § 1.56 Circuit Courts 562 F.2d 1252, 1255 745 F.2d 1437, 1455 816 F.2d 643, 646 849 F.2d 1418, 1422 863 F.2d 867, 876 906 F.2d 684 910 F.2d 804, 809 925 F.2d 1435, 1443 984 F.2d 1182, 1191 19 F.3d 1405 48 F.3d 1172, 1178 72 F.3d 1577, 1585 204 F.3d 1368 323 F.3d 1354, 1359 363 F.3d 1235, 1239 417 F.3d 1230 468 F.3d 1366, 1374-1375 471 F.3d 1293, 1310 476 F.3d 1359, 1363-1365 489 F.3d 935, 943 504 F.3d 1223 390 F. Supp. 2d 936, 938 390 F. Supp. 2d 952, 954 475 F. Supp. 2d 970, 975-982